SOLV
Solventum Corporation NYSE Listed Apr 1, 2024$75.43
+1.17%
vs $74.56
Mkt Cap $13.2B
52w Low $62.49
54.7% of range
52w High $86.14
50d MA $73.33
200d MA $74.38
P/E (TTM)
8.5x
EV/EBITDA
6.8x
P/B
2.6x
Debt/Equity
1.0x
ROE
30.8%
P/FCF
-1322.3x
RSI (14)
51.00
ATR (14)
$2.63
Beta
0.77
50d MA
$73.33
200d MA
$74.38
Avg Volume
2.1M
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.
3M Center · Maplewood, MN 55144 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | 1.35 | 1.48 | +9.6% | 69.04 | -1.5% | +2.8% | +0.9% | +2.4% | +1.0% | +1.3% | — |
| Feb 26, 2026 | AMC | 1.50 | 1.57 | +4.7% | 76.94 | -5.1% | -3.6% | -1.6% | -3.0% | -0.6% | +0.5% | — |
| Nov 6, 2025 | AMC | 1.43 | 1.50 | +4.9% | 66.28 | +3.5% | +7.9% | +0.4% | +2.9% | -0.1% | +1.9% | — |
| Aug 7, 2025 | AMC | 1.45 | 1.69 | +16.6% | 71.95 | +3.4% | +2.0% | -2.1% | +0.3% | +3.2% | -1.6% | — |
| May 8, 2025 | AMC | 1.21 | 1.34 | +10.7% | 66.63 | +2.0% | +5.4% | +6.5% | -1.7% | -3.2% | +2.5% | — |
| Feb 27, 2025 | AMC | 1.31 | 1.41 | +7.6% | 83.44 | -3.0% | -4.4% | +0.5% | -1.5% | -1.5% | -2.7% | — |
| Nov 7, 2024 | AMC | 1.39 | 1.64 | +18.0% | 75.07 | +2.0% | -3.5% | -1.2% | -1.2% | -0.9% | -3.1% | — |
| Aug 8, 2024 | AMC | 1.51 | 1.56 | +3.3% | 58.66 | +2.3% | +3.3% | -4.8% | +0.9% | -0.8% | +1.8% | — |
| May 9, 2024 | AMC | 1.75 | 2.08 | +18.9% | 64.83 | -1.6% | -1.7% | -0.9% | +3.1% | -4.1% | -1.4% | — |
| Dec 31, 2023 | AMC | — | 0.42 | — | — | — | — | — | — | — | — | — |
| Sep 30, 2023 | AMC | — | 1.65 | — | — | — | — | — | — | — | — | — |
| Jun 30, 2023 | AMC | — | 1.86 | — | — | — | — | — | — | — | — | — |
| Mar 31, 2023 | AMC | — | 1.70 | — | — | — | — | — | — | — | — | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15 | Wedbush | Initiates | Outperform | $94 | $74.42 | $74.79 | +0.5% | -0.2% | +2.5% | -1.8% | +1.9% | +0.8% |
| May 14 | UBS | Downgrade | Buy → Neutral | $50 | $74.41 | $73.88 | -0.7% | +0.0% | -0.2% | +2.5% | -1.8% | +1.9% |
| Apr 27 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $68.52 | $68.32 | -0.3% | +1.8% | -3.3% | -1.5% | +1.3% | -1.1% |
| Apr 17 | Piper Sandler | Maintains | Overweight → Overweight | — | $68.88 | $70.00 | +1.6% | +2.3% | -0.6% | -1.5% | +0.2% | -0.2% |
| Feb 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $76.94 | $73.00 | -5.1% | -3.6% | -1.6% | -3.0% | -0.6% | +0.5% |
| Feb 27 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $76.94 | $73.00 | -5.1% | -3.6% | -1.6% | -3.0% | -0.6% | +0.5% |
| Feb 27 | BTIG | Maintains | Buy → Buy | — | $76.94 | $73.00 | -5.1% | -3.6% | -1.6% | -3.0% | -0.6% | +0.5% |
| Jan 26 | KeyBanc Capital Markets | Upgrade | Sector Weight → Overweight | — | $78.91 | $80.13 | +1.5% | +0.1% | -1.8% | -1.3% | -0.1% | +0.6% |
| Jan 20 | Mizuho | Upgrade | Neutral → Outperform | — | $79.48 | $79.56 | +0.1% | -0.7% | +1.8% | -0.1% | -1.7% | +0.1% |
| Jan 7 | Stifel | Maintains | Buy → Buy | — | $83.16 | $83.75 | +0.7% | +1.3% | +1.8% | +0.4% | -0.5% | -6.6% |
| Dec 2 | BTIG | Upgrade | Neutral → Buy | — | $85.56 | $87.30 | +2.0% | +0.0% | -0.4% | +0.0% | +0.2% | -3.3% |
| Nov 10 | UBS | Maintains | Neutral → Neutral | — | $71.52 | $71.25 | -0.4% | +0.4% | +2.9% | -0.1% | +1.9% | +0.6% |
| Nov 7 | Piper Sandler | Maintains | Overweight → Overweight | — | $66.28 | $68.62 | +3.5% | +7.9% | +0.4% | +2.9% | -0.1% | +1.9% |
| Sep 15 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $73.39 | $73.33 | -0.1% | -0.2% | +1.3% | -0.1% | +0.4% | -0.9% |
| Aug 8 | Piper Sandler | Maintains | Overweight → Overweight | — | $71.95 | $74.38 | +3.4% | +2.0% | -2.1% | +0.3% | +3.2% | -1.6% |
| Aug 8 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $71.95 | $74.38 | +3.4% | +2.0% | -2.1% | +0.3% | +3.2% | -1.6% |
| Jul 15 | Morgan Stanley | Upgrade | Equal Weight → Overweight | — | $74.07 | $76.22 | +2.9% | -0.5% | -0.9% | +1.1% | -0.8% | -1.3% |
| Jul 1 | Argus | Upgrade | Hold → Buy | — | $75.84 | $76.73 | +1.2% | +2.7% | +0.5% | +0.3% | -2.9% | -1.5% |
| May 19 | Piper Sandler | Upgrade | Neutral → Overweight | — | $74.11 | $74.75 | +0.9% | +2.2% | -1.4% | -2.6% | -0.1% | -2.5% |
| May 9 | Piper Sandler | Maintains | Neutral → Neutral | — | $66.63 | $67.96 | +2.0% | +5.4% | +6.5% | -1.7% | -3.2% | +2.5% |
| Apr 30 | Piper Sandler | Maintains | Neutral → Neutral | — | $66.25 | $65.68 | -0.9% | -0.2% | -0.8% | +3.0% | -1.1% | -2.1% |
| Mar 5 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $78.99 | $78.80 | -0.2% | -1.5% | -2.7% | +2.9% | -0.4% | -2.3% |
| Mar 3 | Goldman Sachs | Maintains | Sell → Sell | — | $79.75 | $79.76 | +0.0% | +0.5% | -1.5% | -1.5% | -2.7% | +2.9% |
| Mar 3 | Mizuho | Maintains | Neutral → Neutral | — | $79.75 | $79.76 | +0.0% | +0.5% | -1.5% | -1.5% | -2.7% | +2.9% |
| Feb 28 | Piper Sandler | Maintains | Neutral → Neutral | — | $83.44 | $80.95 | -3.0% | -4.4% | +0.5% | -1.5% | -1.5% | -2.7% |
| Feb 28 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $83.44 | $80.95 | -3.0% | -4.4% | +0.5% | -1.5% | -1.5% | -2.7% |
| Feb 26 | BofA Securities | Maintains | Neutral → Neutral | — | $83.56 | $83.50 | -0.1% | +0.6% | -0.7% | -4.4% | +0.5% | -1.5% |
| Nov 11 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $72.43 | $72.22 | -0.3% | -1.2% | -1.2% | -0.9% | -3.1% | -0.6% |
| Nov 8 | Piper Sandler | Maintains | Neutral → Neutral | — | $75.07 | $76.60 | +2.0% | -3.5% | -1.2% | -1.2% | -0.9% | -3.1% |
| Aug 12 | Goldman Sachs | Maintains | Sell → Sell | — | $60.59 | $60.59 | +0.0% | -4.8% | +0.9% | -0.8% | +1.8% | +1.0% |
| Aug 9 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $58.66 | $60.00 | +2.3% | +3.3% | -4.8% | +0.9% | -0.8% | +1.8% |
| Jul 15 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $49.00 | $48.78 | -0.4% | -1.6% | +3.8% | +5.9% | +3.7% | -0.7% |
| Jul 10 | Goldman Sachs | Maintains | Sell → Sell | — | $48.02 | $48.10 | +0.2% | +0.3% | +2.4% | -0.7% | -1.6% | +3.8% |
| Jun 25 | BofA Securities | Maintains | Neutral → Neutral | — | $51.30 | $51.24 | -0.1% | -0.1% | -1.0% | +1.1% | +3.0% | -2.7% |
No insider trades available.
8-K · 5.02
!!! Very High
Solventum Corporation -- 8-K 5.02: Executive Change
Solventum Corporation adopted an executive severance plan effective June 1, 2026, establishing formal severance payment procedures for eligible employees terminated involuntarily.
May 27
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
SOLV's departure of a key executive signals potential leadership instability and operational uncertainty, which could pressure the stock until management clarity emerges.
Mar 24
8-K
Solventum Corporation -- 8-K Filing
Solventum exceeded 2025 full-year sales and EPS expectations with strong fourth-quarter performance, delivering $0.36 GAAP and $1.57 adjusted diluted EPS, signaling operational momentum and execution on transformation initiatives.
Feb 26
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Independent Franchise Partners Llp | 15,733,495 | $1.0B | Added | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 9,601,949 | $627M | New | Mar 2026 |
| 3 | Trian Fund Management, L.p. | 8,236,753 | $538M | — | Mar 2026 |
| 4 | Davis Selected Advisers | 6,220,072 | $493M | Added | Dec 2025 |
| 5 | Vanguard Portfolio Management Llc | 6,390,364 | $417M | New | Mar 2026 |
| 6 | Morgan Stanley | 3,321,812 | $263M | Added | Dec 2025 |
| 7 | Boston Partners | 3,914,091 | $256M | Reduced | Mar 2026 |
| 8 | Invesco Ltd. | 3,789,883 | $247M | Added | Mar 2026 |
| 9 | Diamond Hill Capital Management Inc | 2,109,027 | $167M | Added | Dec 2025 |
| 10 | State Farm Mutual Automobile Insurance Co | 2,069,279 | $135M | — | Mar 2026 |
| 11 | Fmr Llc | 1,870,036 | $122M | Reduced | Mar 2026 |
| 12 | Northern Trust Corp | 1,539,405 | $101M | — | Mar 2026 |
| 13 | Bank Of America Corp /de/ | 1,432,780 | $94M | Added | Mar 2026 |
| 14 | Raymond James Financial Inc | 919,263 | $60M | Added | Mar 2026 |
| 15 | Arrowstreet Capital, Limited Partnership | 883,534 | $58M | Reduced | Mar 2026 |
| 16 | Bank Of New York Mellon Corp | 777,005 | $51M | Reduced | Mar 2026 |
| 17 | Equity Investment Corp | 775,793 | $51M | New | Mar 2026 |
| 18 | Jennison Associates Llc | 625,764 | $50M | Added | Dec 2025 |
| 19 | Aqr Capital Management Llc | 730,045 | $47M | Added | Mar 2026 |
| 20 | Ubs Group Ag | 632,974 | $41M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$13.22B
Enterprise Value
$17.38B
P/E (TTM)
8.49x
Forward P/E
11.66x
PEG Ratio
0.04x
P/B
2.60x
P/S
1.59x
P/FCF
-1322.29x
EV/EBITDA
6.82x
Shares Out
175.3M
Financials (TTM)
Revenue
$8.32B
Net Income
$1.56B
EBITDA
$2.55B
Free Cash Flow
-$10.0M
Op Cash Flow
$369.0M
EPS Basic
$8.94
EPS Diluted
$8.88
EPS Forward
$6.47
Gross Margin
53.5%
Op Margin
26.2%
Net Margin
18.7%
Balance Sheet
Total Assets
$14.29B
Total Liab.
$9.24B
Total Equity
$5.05B
Cash
$878.0M
LT Debt
$5.04B
Book Value/Sh
$29.00
Debt/Equity
1.00x
Current Ratio
1.23
Quick Ratio
0.89
Returns & Growth
ROE
30.8%
ROA
10.9%
ROIC
17.8%
Rev Growth YoY
+0.9%
EPS Growth YoY
+222.7%
Price Returns
2W
+0.7%
1M
+11.3%
3M
+1.0%
6M
-12.1%
12M
+2.5%
Technicals
52W High
$86.14
52W Low
$62.49
50d MA
$73.33
200d MA
$74.38
RSI (14)
51.00
ATR (14)
$2.63
Beta
0.77
Avg Volume
2.1M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$97.80
High
$105.00
Low
$92.00
Median
$100.00
Data updated apr 27, 2026 2:24am
· Source: financialmodelingprep.com